...
首页> 外文期刊>The Australian and New Zealand journal of psychiatry >Positive and negative symptoms in schizophrenia: the NMDA receptor hypofunction hypothesis, neuregulin/ErbB4 and synapse regression.
【24h】

Positive and negative symptoms in schizophrenia: the NMDA receptor hypofunction hypothesis, neuregulin/ErbB4 and synapse regression.

机译:精神分裂症的阳性和阴性症状:NMDA受体功能低下假说,神经调节蛋白/ ErbB4和突触消退。

获取原文
获取原文并翻译 | 示例
           

摘要

Carlsson has put forward the hypothesis that the positive and negative symptoms of schizophrenia are due to failure of mesolimbic and mesocortical projections consequent on hypofunction of the glutamate N-methyl-d-aspartate (NMDA) receptor. The hypothesis has been recently emphasized in this Journal that the loss of synaptic spines with NMDA receptors, which can be precipitated by stress, can explain the emergence of positive symptoms such as hallucinations and that this synapse regression involves molecules such as neuregulin and its receptor ErbB4 that have been implicated in schizophrenia. In this essay these two hypotheses are brought together in a single scheme in which emphasis is placed on the molecular pathways from neuregulin/ErbB4, to modulation of the NMDA receptors, subsequent changes in the synaptic spine's cytoskeletal apparatus and so regression of the spines. It is suggested that identification of the molecular constituents of this pathway will allow synthesis of suitable substances for removing the hypofunction of NMDA receptors and so the phenotypic consequences that flow from this hypofunction.
机译:Carlsson提出了以下假设:精神分裂症的阳性和阴性症状是由于谷氨酸N-甲基-d-天冬氨酸(NMDA)受体功能减退导致的中脑边缘和中皮层预测的失败。该杂志最近强调了这一假设,即NMDA受体引起的突触棘的丧失可能由压力引起,可以解释诸如幻觉的阳性症状的出现,并且这种突触消退涉及诸如神经调节蛋白及其受体ErbB4的分子。与精神分裂症有关。在本文中,这两个假设被整合到一个单一的方案中,其中重点放在从神经调节蛋白/ ErbB4到NMDA受体的调节,突触脊柱细胞骨架设备的后续变化以及脊柱消退的分子途径上。建议鉴定该途径的分子组成将允许合成合适的物质以消除NMDA受体的功能减退,从而消除这种功能减退的表型后果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号